Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: Possible role of Akt and IRAK-M

Journal of Hepatology

Volumn 45, Issue 2, 2006, Pages 280-289

  Tazi, Khalid A ^a   Quioc, Jean Jacques ^a   Saada, Véronique ^a   Bezeaud, Annie ^a   Lebrec, Didier ^a   Moreau, Richard ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Cirrhosis; LPS; MAP kinases; Monocytes; NF kappaB; TLR4; TNF alpha

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE M; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LIVER CIRRHOSIS; MALE; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MONOCYTES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33745845536     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.02.013     Document Type: Article

References (41)

1. Girón-González J.A., Martínez-Sierra C., Rodriguez-Ramos C., Macías M.A., Rendón P., Díaz F., et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 24 (2004) 437-445
2. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005;54:718-725.
3. Tazi K.A., Moreau R., Herve P., Dauvergne A., Cazals-Hatem D., Bert F., et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 129 (2005) 303-314
4. Van der Meide P.H., and Schellekens H. Cytokines and the immune response. Biotherapy 82 (1996) 43-49
5. Anderson K.V. Toll signaling pathways in the innate immune response. Curr Opin Immunol 12 (2000) 13-19
6. Albillos A., Hera Ad Ade L., Reyes E., Monserrat J., Munoz L., Nieto M., et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 40 (2004) 624-631
7. Lin R.S., Lee F.Y., Lee S.D., Tsai Y.T., Lin H.C., Lu R.H., et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22 (1995) 165-172
8. Guarner C., and Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 17 (2005) 27-31
9. Heller J., Sogni P., Barriere E., Tazi K.A., Chauvelot-Moachon L., Guimont M.C., et al. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 33 (2000) 376-381
10. Moreau R., Barriere E., Tazi K.A., Lardeux B., Dargere D., Urbanowicz W., et al. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis. Hepatology 36 (2002) 1070-1078
11. Urbanowicz W., Sogni P., Moreau R., Tazi K.A., Barriere E., Poirel O., et al. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats. Gut 53 (2004) 1844-1849
12. McClain C.J., and Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9 (1989) 349-351
13. Deviere J., Content J., Denys C., Vandenbussche P., Schandene L., Wybran J., et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 11 (1990) 628-634
14. Riordan S.M., Skinner N., Nagree A., McCallum H., McIver C.J., Kurtovic J., et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37 (2003) 1154-1164
15. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
16. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
17. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 (2001) 78-83
18. Guha M., and Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277 (2002) 32124-32132
19. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561
20. Jefferies C.A., Doyle S., Brunner C., Dunne A., Brint E., Wietek C., et al. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem 278 (2003) 26258-26264
21. Liu M.K., Herrera-Velit P., Brownsey R.W., and Reiner N.E. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 153 (1994) 2642-2652
22. Swantek J.L., Cobb M.H., and Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 17 (1997) 6274
23. Hambleton J., Weinstein S.L., Lem L., and DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 93 (1996) 2774
24. Rao K.M. MAP kinase activation in macrophages. J Leukoc Biol 69 (2001) 3-10
25. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., and Vogel S.N. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 169 (2002) 5209-5216
26. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A., Medzhitov R., and Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
27. Fan H., and Cook J.A. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 10 (2004) 71-84
28. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 24 (2003) 358-363
29. Mao T.K., Lian Z.X., Selmi C., Ichiki Y., Ashwood P., Ansari A.A., et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology 42 (2005) 802-808
30. Bosisio D., Polentarutti N., Sironi M., Bernasconi S., Miyake K., Webb G.R., et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99 (2002) 3427-3431
31. Wolfs T.G., Buurman W.A., van Schadewijk A., de Vries B., Daemen M.A., Hiemstra P.S., et al. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J Immunol 168 (2002) 1286-1293
32. Faure E., Thomas L., Xu H., Medvedev A., Equils O., and Arditi M. Bacterial lipopolysaccharide and IFN-α induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J Immunol 166 (2001) 2018-2024
33. Matsumura T., Ito A., Takii T., Hayashi H., and Onozaki K. Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res 20 (2000) 915-921
34. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., and Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166 (2001) 249-255
35. Manigold T., Bocker U., Hanck C., Gundt J., Traber P., Antoni C., et al. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 15 (2003) 275-282
36. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
37. Guha M., O'Connell M.A., Pawlinski R., Hollis A., McGovern P., Yan S.F., et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98 (2001) 1429-1439
38. Means T.K., Pavlovich R.P., Roca D., Vermeulen M.W., and Fenton M.J. Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukoc Biol 67 (2000) 885-893
39. MacKenzie S., Fernandez-Troy N., and Espel E. Post-transcriptional regulation of TNF-alpha during in vitro differentiation of human monocytes/macrophages in primary culture. J Leukoc Biol 71 (2002) 1026-1032
40. Rasaratnam B., Kaye D., Jennings G., Dudley F., and Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 139 (2003) 186-193
41. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 3 (2002) 392-398